Revised In Commerce List (R-ICL) Review

 In news, Regulatory Affairs

Update: Revised In Commerce List (R-ICL)

By: Teri Dickinson, Manager, Regulatory Affairs Specialist, email

On April 7, 2018, the Notice of Intent announcing the closure of the nomination of substances on the R-ICL was published in Part 1 of the Canada Gazette with a 60-day comment period. It is suggested that any company that submitted nominations review this document and submit comments.

Nominations to the R-ICL will continue to be accepted until one year following publication of a final notice of intent. However, in order to create a static list that will allow the prioritization of substances on the R-ICL to be finalized, the nomination process will be terminated at that time, and no further nominations will be accepted. From that date, manufacturers and importers who wish to market a new substance for use in a Food & Drugs Act-regulated product in Canada that are not already listed on the R-ICL must submit a notification under the New Substance Notification Regulations (NSNR).

Dell Tech Laboratories

Dell Tech has provided professional, confidential consulting services to the chemical specialty

industry in Canada, the USA, Europe, and Asia for the last 40 years.

Contact us today for more information.


Recommended Posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.